Duloxetine Attenuates Paclitaxel-Induced Peripheral Nerve Injury by Inhibiting p53-Related Pathways

Yuting Lu(Shanghai Institute of Materia Medica), Jing Zhu(Nanjing University of Chinese Medicine)
Journal of Pharmacology and Experimental Therapeutics
April 2, 2020
10.1124/jpet.120.265082
Cited by 35

Related Papers

Duloxetine, a Balanced Serotonin-Norepinephrine Reuptake Inhibitor, Improves Painful Chemotherapy-Induced Peripheral Neuropathy by Inhibiting Activation of p38 MAPK and NF-κB
|Frontiers in Pharmacology|2019|86
Long-term non-invasive drug treatments in adult zebrafish that lead to melanoma drug resistance
|Disease Models & Mechanisms|2022|21
Sulfuretin protects hepatic cells through regulation of ROS levels and autophagic flux
|Acta Pharmacologica Sinica|2018|20
ALDH1A3-acetaldehyde metabolism potentiates transcriptional heterogeneity in melanoma
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1
The Role of Formononetin in Cerebral Ischemia-Reperfusion Injury: A New Mediator of c-Fos/IL-10/STAT3 Signaling Pathway
|Frontiers in Bioscience-Landmark|2025|1